Virtus LifeSci Biotech Pr... (BBP)
NYSEArca: BBP
· Echtzeitkurs · USD
101.31
+0.22 (0.22%)
Zum Schluss: Aug 14, 2026, 3:54 PM
101.33
+0.02%
Nachbörslich: 7:49 PM
Virtus LifeSci Biotech Products ETF (BBP) ETF Price, Holdings & Analysis
0.22% (1D)
| Geld | k.A. |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 98.54 Mio |
| NAV | k.A. |
| Beta | k.A. |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | k.A. |
| Ausstehende Anteile | k.A. |
| Auflagedatum | k.A. |
| Brief | k.A. |
| Volumen | 11,182 |
| Ø Vol. (20D) | k.A. |
| Eröffnung | 101.16 |
| Vortagesschluss | 101.09 |
| Tagesspanne | 99.81 - 101.33 |
| 52-Wk Range | 66.55 - 105.21 |
| Positionen | k.A. |
| Kostenquote | 0.34% |
Über BBP
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Anlageklasse Equity
Tickersymbol BBP
Auflagedatum n/a
Anbieter Virtus
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 19.61% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.34% |
| Kiniksa Pharmaceutic... | KNSA | 1.97% |
| Verastem Inc | VSTM | 1.95% |
| Precigen Inc | PGEN | 1.94% |
| Omeros Corp | OMER | 1.87% |
| Nuvation Bio Inc Ord... | NUVB | 1.77% |
| Regeneron Pharmaceut... | REGN | 1.72% |
| Protagonist Therapeu... | PTGX | 1.71% |
| Acadia Pharmaceutica... | ACAD | 1.69% |
| Bridgebio Pharma Inc | BBIO | 1.65% |
Dividenden Dividendenrendite 0.07%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 20, 2017 | $0.0720 | k.A. |
| Dec 21, 2015 | $0.3970 | k.A. |
